These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1375405)
1. Modulation of T-cell reactivity to synthetic peptide analogues of foot-and-mouth disease virus in sheep by amino acid substitutions. Flynn JN; Harkiss GD; Moore D; DiMarchi R Vet Immunol Immunopathol; 1992 Mar; 31(3-4):255-66. PubMed ID: 1375405 [TBL] [Abstract][Full Text] [Related]
2. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1. Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465 [TBL] [Abstract][Full Text] [Related]
3. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice. Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431 [TBL] [Abstract][Full Text] [Related]
4. Analysis of immune responses in the sheep to synthetic peptides of foot-and-mouth disease virus using ovine polyclonal and monoclonal antibodies. Flynn JN; Harkiss GD; Doel T; DiMarchi R Immunology; 1990 Jan; 69(1):1-7. PubMed ID: 1690176 [TBL] [Abstract][Full Text] [Related]
5. Immune response to uncoupled peptides of foot-and-mouth disease virus. Francis MJ; Fry CM; Rowlands DJ; Bittle JL; Houghten RA; Lerner RA; Brown F Immunology; 1987 May; 61(1):1-6. PubMed ID: 3034769 [TBL] [Abstract][Full Text] [Related]
6. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus. Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606 [TBL] [Abstract][Full Text] [Related]
7. A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection. Volpina OM; Surovoy AY; Zhmak MN; Kuprianova MA; Koroev DO; Chepurkin AV; Toloknov AS; Ivanov VT Vaccine; 1999 Feb; 17(6):577-84. PubMed ID: 10075164 [TBL] [Abstract][Full Text] [Related]
8. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477 [TBL] [Abstract][Full Text] [Related]
9. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos. Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548 [TBL] [Abstract][Full Text] [Related]
11. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534 [TBL] [Abstract][Full Text] [Related]
12. Antibodies elicited by a biosynthetic peptide related to a major immunogenic area of FMDV A12. Borca MV; Moore DM; Srikumaran S; Morgan DO Viral Immunol; 1990; 3(2):147-60. PubMed ID: 1694429 [TBL] [Abstract][Full Text] [Related]
13. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example. Vol'pina OM; Surovoi AYu ; Ivanov VT Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462 [TBL] [Abstract][Full Text] [Related]
14. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22]. Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673 [TBL] [Abstract][Full Text] [Related]
15. Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. van Lierop MJ; van Maanen K; Meloen RH; Rutten VP; de Jong MA; Hensen EJ Immunology; 1992 Mar; 75(3):406-13. PubMed ID: 1349300 [TBL] [Abstract][Full Text] [Related]
17. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif. Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234 [TBL] [Abstract][Full Text] [Related]
18. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus]. Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134 [TBL] [Abstract][Full Text] [Related]
19. Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes. Garcia-Valcarcel M; Doel T; Collen T; Ryan M; Parkhouse RM J Gen Virol; 1996 Apr; 77 ( Pt 4)():727-35. PubMed ID: 8627261 [TBL] [Abstract][Full Text] [Related]
20. Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. van Lierop MJ; Wagenaar JP; van Noort JM; Hensen EJ J Virol; 1995 Jul; 69(7):4511-4. PubMed ID: 7769713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]